A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity, Science, vol.337, issue.6096, pp.816-821, 2012. ,
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria, Proc. Natl. Acad. Sci. U.S.A, vol.109, issue.39, pp.2579-2586, 2012. ,
Multiplex genome engineering using CRISPR/Cas systems, Science, vol.339, issue.6121, pp.819-823, 2013. ,
RNA-guided human genome engineering via Cas9, Science, vol.339, issue.6121, pp.823-826, 2013. ,
Development and applications of CRISPR-Cas9 for genome engineering, Cell, vol.157, issue.6, pp.1262-1278, 2014. ,
The new frontier of genome engineering with CRISPR-Cas9, Science, vol.346, issue.6213, p.1258096, 2014. ,
CRISPR-Cas systems for editing, regulating and targeting genomes, Nat. Biotechnol, vol.32, issue.4, pp.347-355, 2014. ,
Mutational landscape and significance across 12 major cancer types, Nature, vol.502, issue.7471, pp.333-339, 2013. ,
, Cancer genome landscapes, vol.339, issue.6127, pp.1546-1558, 2013.
Repurposing CRISPR/Cas9 for in situ functional assays, Genes Dev, vol.27, issue.23, pp.2602-2614, 2013. ,
A versatile modular vector system for rapid combinatorial mammalian genetics, J. Clin. Invest, vol.125, issue.4, pp.1603-1619, 2015. ,
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia, Cancer Cell, vol.25, issue.5, pp.652-665, 2014. ,
Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer, Oncogene, 2016. ,
Identifying drug-target selectivity of small-molecule CRM1/XPO1 inhibitors by CRISPR/Cas9 genome editing, Chem. Biol, vol.22, issue.1, pp.107-116, 2015. ,
Genome-scale CRISPR-Cas9 knockout screening in human cells, Science, vol.343, issue.6166, pp.84-87, 2014. ,
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex, Nature, vol.517, issue.7536, pp.583-588, 2015. ,
Highresolution interrogation of functional elements in the noncoding genome, Science, vol.353, issue.6307, pp.1545-1549, 2016. ,
The noncoding RNAs SNORD50A and SNORD50B bind K-Ras and are recurrently deleted in human cancer, Nat. Genet, vol.48, issue.1, pp.53-58, 2016. ,
Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers, Nature, vol.534, issue.7607, pp.402-406, 2016. ,
Targeted genomic rearrangements using CRISPR/Cas technology, Nat. Commun, vol.5, p.3728, 2014. ,
Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system, Nat. Commun, vol.5, p.3964, 2014. ,
Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids, Nat. Med, vol.21, issue.3, pp.256-262, 2015. ,
Sequential cancer mutations in cultured human intestinal stem cells, Nature, vol.521, issue.7550, pp.43-47, 2015. ,
A genetic model for colorectal tumorigenesis, Cell, vol.61, issue.5, pp.759-767, 1990. ,
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche, Nature, vol.459, issue.7244, pp.262-265, 2009. ,
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing, Nat. Biotechnol, vol.32, issue.9, pp.941-946, 2014. ,
Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis, Cell, vol.160, issue.6, pp.1246-1260, 2015. ,
CRISPR-mediated direct mutation of cancer genes in the mouse liver, Nature, vol.514, issue.7522, pp.380-384, 2014. ,
Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling, Nat. Commun, vol.6, p.7391, 2015. ,
Rapid modelling of cooperating genetic events in cancer through somatic genome editing, Nature, vol.516, issue.7531, pp.428-431, 2014. ,
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system, Nature, vol.516, issue.7531, pp.423-427, 2014. ,
Simple and rapid in vivo generation of chromosomal rearrangements using CRISPR/Cas9 technology, Cell Rep, vol.9, issue.4, pp.1219-1227, 2014. ,
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma, Nat. Med, vol.21, issue.10, pp.1163-1171, 2015. ,
CRISPRCas9 knockin mice for genome editing and cancer modeling, Cell, vol.159, issue.2, pp.440-455, 2014. ,
Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing, Genes Dev, vol.29, issue.14, pp.1576-1585, 2015. ,
Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland, Genes Dev, vol.30, issue.12, pp.1470-1480, 2016. ,
Inducible in vivo genome editing with CRISPR-Cas9, Nat. Biotechnol, vol.33, issue.4, pp.390-394, 2015. ,
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity, Cell, vol.154, issue.6, pp.1380-1389, 2013. ,
Evolutionary dynamics of carcinogenesis and why targeted therapy does not work, Nat. Rev. Cancer, vol.12, issue.7, pp.487-493, 2012. ,
Clonal evolution in cancer, Nature, vol.481, issue.7381, pp.306-313, 2012. ,
Biological and therapeutic impact of intratumor heterogeneity in cancer evolution, Cancer Cell, vol.27, issue.1, pp.15-26, 2015. ,
Tumor heterogeneity: causes and consequences, Biochim. Biophys. Acta, vol.1805, issue.1, pp.105-117, 2010. ,
Tumor heterogeneity confounds and illuminates: assessing the implications, Nat. Med, vol.20, issue.4, pp.342-344, 2014. ,
Toward understanding and exploiting tumor heterogeneity, Nat. Med, vol.21, issue.8, pp.846-853, 2015. ,
CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences, Nucleic Acids Res, vol.42, issue.11, pp.7473-7485, 2014. ,
Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors, Nat. Biotechnol, vol.33, issue.2, pp.175-178, 2015. ,
CRISPR-barcoding for intratumor genetic heterogeneity modeling and functional analysis of oncogenic driver mutations, Mol. Cell, vol.63, issue.3, pp.526-538, 2016. ,
DNA barcoding reveals diverse growth kinetics of human breast tumour subclones in serially passaged xenografts, Nat. Commun, vol.5, p.5871, 2014. ,
Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells, Nature, 2015. ,
Studying clonal dynamics in response to cancer therapy using high-complexity barcoding, Nat. Med, vol.21, issue.5, pp.440-448, 2015. ,
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition, Nat. Med, vol.22, issue.3, pp.262-269, 2016. ,